“Long-term Safety and Efficacy of Belzutifan in Von Hippel–Lindau Syndrome: A VHL Coordinating Care Center Experience”, jkcvhl, vol. 12, no. 3, pp. 25–31, Sep. 2025, doi: 10.15586/jkcvhl.v12i3.425.